Boswellia serrata extract contains boswellic acids — potent anti-inflammatory compounds that inhibit 5-lipoxygenase (5-LOX), a pathway not targeted by NSAIDs or COX inhibitors. Our research shows strong evidence for osteoarthritis pain relief and moderate evidence for inflammatory bowel disease. It works through a different mechanism than ibuprofen, making it a potential complement — not a replacement — for conventional anti-inflammatory therapy.
Boswellic acids (AKBA — acetyl-11-keto-β-boswellic acid is the most active) specifically inhibit 5-lipoxygenase, the enzyme that produces leukotrienes. Leukotrienes are inflammatory mediators involved in asthma, allergies, and chronic inflammatory conditions. This mechanism is unique — NSAIDs target COX-1/COX-2, corticosteroids broadly suppress immune function, but boswellia specifically targets the 5-LOX pathway.
AKBA also inhibits NF-κB, human leukocyte elastase, and microsomal prostaglandin E2 synthase. The anti-inflammatory effect is potent but narrower than corticosteroids.
Different mechanism; may be additive anti-inflammatory but also additive GI risk
Boswellia has mild antiplatelet activity; case report of increased INR
In vitro inhibition of multiple CYP enzymes — clinical significance unclear but exercise caution with narrow therapeutic index drugs
Anti-inflammatory properties may modulate immune function
Not Prohibited
Bannuru RR et al. Efficacy of curcumin and Boswellia for knee osteoarthritis: systematic review and meta-analysis.
Gupta I et al. Effects of Boswellia serrata gum resin in patients with bronchial asthma.
Gupta I et al. Effects of Boswellia serrata gum resin in patients with ulcerative colitis.
Sontakke S et al. Open, randomized, controlled clinical trial of Boswellia serrata extract in osteoarthritis of knee.
Reviewed by the Scan Dose Research Team and Clinical Advisory Board | Last updated: April 2026
Not medical advice. Based on published clinical research and systematic reviews.